-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q1 2023.
- Freeline Therapeutics Holdings plc Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $162K, a 636% increase year-over-year.
- Freeline Therapeutics Holdings plc annual Income Tax Expense (Benefit) for 2022 was $368K, a 7.6% increase from 2021.
- Freeline Therapeutics Holdings plc annual Income Tax Expense (Benefit) for 2021 was $342K, a 165% increase from 2020.
- Freeline Therapeutics Holdings plc annual Income Tax Expense (Benefit) for 2020 was $129K, a 8.51% decline from 2019.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)